Press release
September 28, 2021
Immunicom’s Alternative Subtractive Cancer Therapy Recognized with Zoom’s Healthcare Innovation Award
September 21, 2021
Immunicom Introduces 2nd Product of Immunopheresis® Therapy Platform Designed to Suppress Cancer Progression and Overcome Therapeutic Resistance
September 14, 2021
Immunicom Presents Promising Preliminary Data from Immunopheresis® Studies in Late-Stage Cancer Patients at JCA-AACR 2021
August 31, 2021
Immunicom Hires World-Renowned Oncologist to Rapidly Progress Launch of Non-Pharmaceutical Cancer Therapy
August 16, 2021